IL73885A - 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it - Google Patents

2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it

Info

Publication number
IL73885A
IL73885A IL73885A IL7388584A IL73885A IL 73885 A IL73885 A IL 73885A IL 73885 A IL73885 A IL 73885A IL 7388584 A IL7388584 A IL 7388584A IL 73885 A IL73885 A IL 73885A
Authority
IL
Israel
Prior art keywords
preparation
compositions containing
antibiotic compositions
erythromycin stearate
acetyl erythromycin
Prior art date
Application number
IL73885A
Other languages
English (en)
Other versions
IL73885A0 (en
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of IL73885A0 publication Critical patent/IL73885A0/xx
Publication of IL73885A publication Critical patent/IL73885A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
IL73885A 1984-01-06 1984-12-20 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it IL73885A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (2)

Publication Number Publication Date
IL73885A0 IL73885A0 (en) 1985-03-31
IL73885A true IL73885A (en) 1988-10-31

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73885A IL73885A (en) 1984-01-06 1984-12-20 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it

Country Status (38)

Country Link
US (1) US4599326A (cs)
JP (1) JPS60158197A (cs)
KR (1) KR900006237B1 (cs)
AT (1) AT386414B (cs)
AU (1) AU565688B2 (cs)
BE (1) BE901411A (cs)
BG (1) BG43189A3 (cs)
CA (1) CA1224461A (cs)
CH (1) CH666275A5 (cs)
CS (1) CS247191B2 (cs)
CY (1) CY1462A (cs)
DE (1) DE3500179A1 (cs)
DK (1) DK149776C (cs)
ES (1) ES8605818A1 (cs)
FI (1) FI77249C (cs)
FR (1) FR2557878B1 (cs)
GB (1) GB2152502B (cs)
HK (1) HK11590A (cs)
HU (1) HU196221B (cs)
IE (1) IE57967B1 (cs)
IL (1) IL73885A (cs)
IS (1) IS2968A7 (cs)
IT (1) IT1184304B (cs)
KE (1) KE3841A (cs)
LU (1) LU85721A1 (cs)
MA (1) MA20316A1 (cs)
MX (1) MX156277A (cs)
NL (1) NL8403979A (cs)
NO (1) NO160263C (cs)
NZ (1) NZ210606A (cs)
PH (1) PH22471A (cs)
PL (1) PL144349B1 (cs)
PT (1) PT79777B (cs)
RO (1) RO91262B (cs)
SE (1) SE461854B (cs)
SU (1) SU1410866A3 (cs)
YU (1) YU44485B (cs)
ZA (1) ZA8410143B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
AU2003247876B2 (en) * 2002-07-05 2006-10-05 Collegium Pharmaceutical, Inc Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP1677759A1 (en) * 2003-10-31 2006-07-12 Alza Corporation Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
CA2714867A1 (en) 2006-06-23 2007-12-27 Candace B. Pert Non-aggregated pharmaceutically active peptide
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP3566711A1 (en) 2011-05-18 2019-11-13 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
CN117903257A (zh) 2012-11-20 2024-04-19 梅德瑞斯糖尿病有限责任公司 用于胰岛素抗性的改良的肽药物
ES2906975T3 (es) 2012-11-20 2022-04-21 Eumederis Pharmaceuticals Inc Productos farmacéuticos de péptidos mejorados
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
IL285613B2 (en) 2014-05-28 2024-11-01 Mederis Diabetes Llc Improved peptide pharmaceuticals for insulin resistance
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
CU20190092A7 (es) * 2017-05-19 2020-10-20 Lunella Biotech Inc Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CA3088989C (en) 2018-02-06 2023-03-07 Ars Pharmaceuticals Inc. Intranasal epinephrine formulations and methods for the treatment of disease
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
KR20210104829A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 미토콘드리아를 표적화하고 암 줄기 세포를 사멸시키는 삼중 조합 요법
WO2020131704A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for anti-aging

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
PH22471A (en) 1988-09-12
RO91262B (ro) 1987-07-01
YU44485B (en) 1990-08-31
PL251457A1 (en) 1985-11-05
MA20316A1 (fr) 1985-10-01
FI77249C (fi) 1989-02-10
PT79777B (en) 1986-10-21
LU85721A1 (fr) 1985-07-24
YU2085A (en) 1987-12-31
MX156277A (es) 1988-08-04
KR850005452A (ko) 1985-08-26
HU196221B (en) 1988-10-28
HK11590A (en) 1990-02-23
NO160263C (no) 1989-03-29
NL8403979A (nl) 1985-08-01
ATA985A (de) 1988-01-15
IL73885A0 (en) 1985-03-31
IT8519012A0 (it) 1985-01-04
DK149776B (da) 1986-09-29
CY1462A (en) 1989-07-21
CA1224461A (en) 1987-07-21
CH666275A5 (de) 1988-07-15
JPH029040B2 (cs) 1990-02-28
IE57967B1 (en) 1993-06-02
DK5884A (da) 1985-07-07
IE850022L (en) 1985-07-06
SE8406671L (sv) 1985-07-07
FR2557878A1 (fr) 1985-07-12
NZ210606A (en) 1987-08-31
AU565688B2 (en) 1987-09-24
PT79777A (en) 1985-01-01
DE3500179A1 (de) 1985-07-18
RO91262A (ro) 1987-06-30
DE3500179C2 (cs) 1989-08-24
SE8406671D0 (sv) 1984-12-28
US4599326A (en) 1986-07-08
CS247191B2 (en) 1986-12-18
GB8432368D0 (en) 1985-02-06
IS2968A7 (is) 1985-04-03
IT1184304B (it) 1987-10-28
ES539349A0 (es) 1986-04-01
BG43189A3 (en) 1988-04-15
FI850023A0 (fi) 1985-01-03
ES8605818A1 (es) 1986-04-01
JPS60158197A (ja) 1985-08-19
KE3841A (en) 1989-04-07
KR900006237B1 (ko) 1990-08-27
NO850007L (no) 1985-07-08
DK5884D0 (da) 1984-01-06
HUT37628A (en) 1986-01-23
BE901411A (fr) 1985-04-16
ZA8410143B (en) 1985-08-28
PL144349B1 (en) 1988-05-31
DK149776C (da) 1987-04-21
GB2152502A (en) 1985-08-07
AT386414B (de) 1988-08-25
AU3705984A (en) 1985-07-11
GB2152502B (en) 1987-10-07
FR2557878B1 (fr) 1988-01-15
FI850023L (fi) 1985-07-07
SE461854B (sv) 1990-04-02
FI77249B (fi) 1988-10-31
SU1410866A3 (ru) 1988-07-15
NO160263B (no) 1988-12-19

Similar Documents

Publication Publication Date Title
IL73885A (en) 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it
IL76385A (en) S 541 macrolides and their preparation,and pharmaceutical and pesticidal compositions containing them
EP0246739A3 (en) Macrolide compounds, their preparation and their use
IL89996A0 (en) Macrolide compositions
NZ211895A (en) 1,4-dihydro-4-oxonaphthyridine derivatives, and antibacterial compositions containing such
IL93914A0 (en) 4(3h)-pteridinones,their preparation and pharmaceutical compositions containing them
EG18720A (en) Macrolide compounds, their preparation and their use
GB2192630B (en) Macrolide compounds
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
IL86888A0 (en) 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
IL94600A0 (en) Pyridobenzoindole compounds,their preparation and compositions containing them
GB2238540B (en) 13-deoxy-4'-deoxy-4'-iodoanthracyclines
GB2187742B (en) Macrolide compound
EP0242052A3 (en) Macrolide compounds
GB8913288D0 (en) Antiparasitic macrolide compositions
GB8500263D0 (en) 4'-deoxy-4'-halodoxorubicin-14-esters
GB8809615D0 (en) 4-demethoxy-4'-deoxy-4'-iodo anthracy-cline glycosides
IE862753L (en) Compositions containing tylosin and a beta-lactam¹antibiotic.
ZA871759B (en) Macrolide compound
ZA857049B (en) Antibiotic compounds and their preparation
IE893701L (en) 2'-deoxy-4'-azido-substituted nucleosides
PH24384A (en) Aminoalkanoyl-dibenzo (d,g) (1,3,6) dioxazocines and composition thereof
CS738884A1 (en) Kmen mikroorganizmu streptomyces fradiae ccm 3765
GB8801423D0 (en) Water-soluble antibiotic composition
IE883510L (en) Antibiotic compositions

Legal Events

Date Code Title Description
RH Patent void